Literature DB >> 20230524

HLA-A, -B, -DR haplotype frequencies in the Thai Stem Cell Donor Registry.

P Kupatawintu1, S Pheancharoen, A Srisuddee, H Tanaka, K Tadokoro, O Nathalang.   

Abstract

This study aimed to report antigen and haplotype frequencies (HFs) in the Thai Stem Cell Donor Registry (TSCDR). From 16,807 human leukocyte antigen (HLA)-A, -B, and -DR typed donors, 19 HLA-A, 41 HLA-B, and 13 HLA-DR antigens were found. HLA-A43, A80, B78, B82, B83, and DR18 were not observed. A total of 1921 haplotypes were estimated and 245 haplotypes were reliable and their cumulative HF was 75.74%. Similar to previous Thai subpopulation studies, the most common haplotypes were HLA-A33-B58-DR17 (4.54%), A2-B46-DR9 (4.11%), A33-B44-DR7 (2.85%), and A11-B75-DR12 (2.00%). To evaluate the probability in finding matched donors, from April 2002 to August 2008, 793 Thai patients were requested for unrelated stem cell donor searching. The number of patients with HLA-A, -B, -DR split matched donor found were 49%. Only 8% of the patients found matched donor within 1 month. However, high-resolution HLA-A, -B, -DR typing in TSCDR is suggested to accurately estimate HFs and evaluate the probability in finding a matched donor for patients in the future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20230524     DOI: 10.1111/j.1399-0039.2010.01450.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial.

Authors:  Heather A Prentice; Philip K Ehrenberg; Karen M Baldwin; Aviva Geretz; Charla Andrews; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; Robert J O'Connell; Merlin L Robb; Jerome H Kim; Nelson L Michael; Rasmi Thomas
Journal:  Immunogenetics       Date:  2014-03-29       Impact factor: 2.846

2.  Human neutrophil alloantigen genotype frequencies in Thai blood donors.

Authors:  Khaimuk Changsri; Pussadee Tobunluepop; Dujdow Songthammawat; Teerakul Apornsuwan; Chollanot Kaset; Oytip Nathalang
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

3.  HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivity.

Authors:  Apichaya Puangpetch; Napatrupron Koomdee; Montri Chamnanphol; Thawinee Jantararoungtong; Siwalee Santon; Santirhat Prommas; Yaowaluck Hongkaew; Chonlaphat Sukasem
Journal:  Front Genet       Date:  2015-01-22       Impact factor: 4.599

4.  HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population.

Authors:  Nontaya Nakkam; Parinya Konyoung; Sirimas Kanjanawart; Niwat Saksit; Thachanan Kongpan; Kanyarat Khaeso; Usanee Khunarkornsiri; Areerat Dornsena; Wongwiwat Tassaneeyakul; Wichittra Tassaneeyakul
Journal:  Front Genet       Date:  2018-08-06       Impact factor: 4.599

5.  CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication.

Authors:  Hayato Murakoshi; Chengcheng Zou; Nozomi Kuse; Tomohiro Akahoshi; Takayuki Chikata; Hiroyuki Gatanaga; Shinichi Oka; Tomáš Hanke; Masafumi Takiguchi
Journal:  Retrovirology       Date:  2018-07-03       Impact factor: 4.602

6.  Association between HLA-B*46 allele and Graves disease in Asian populations: a meta-analysis.

Authors:  Yiping Li; Yufeng Yao; Man Yang; Li Shi; Xianli Li; Ying Yang; Ying Zhang; Chunjie Xiao
Journal:  Int J Med Sci       Date:  2013-01-03       Impact factor: 3.738

7.  The Association Between HLA Class II Alleles and the Occurrence of Factor VIII Inhibitor in Thai Patients with Hemophilia A.

Authors:  Oytip Nathalang; Pramote Sriwanitchrak; Werasak Sasanakul; Ampaiwan Chuansumrit
Journal:  Turk J Haematol       Date:  2012-03-05       Impact factor: 1.831

8.  An analysis of HLA-A, -B, and -DRB1 allele and haplotype frequencies of 21,918 residents living in Liaoning, China.

Authors:  Xiao-Feng Li; Xu Zhang; Yang Chen; Kun-Lian Zhang; Xiang-Jun Liu; Jian-Ping Li
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.